REMINDER: Our user survey closes on Friday, please submit your responses here.
Held off buying in until today to confirm all was well with the results, missed out on the 9% increase but happy to wait for further gains. Revenue up, debt down, cash in the bank and plenty of opportunity for growth. As u said Bazzaman Simon Thomson should give this a nudge in the right direction if he covers them again next week. 170p certainly possible over the next 12 months, slow and steady.
Well the gentle rise I had hoped for this morning turning into a 19% increase was extremely welcome! I will have to wait a while to recoup my paper loss, but given the gradual fall from grace over the last 12 months this should push higher over the next few weeks as brokers and ‘experts’ turn positive, we shall see.......
Having advised selling Hikma back in August last year (which is when I should’ve heeded their advice!) they have now turned bullish on the company. Stating ‘trading on 14 times forward earnings, the shares are cheap for a global Pharma company. The generics industry is still tough, but with new management and more clarity on generic Advair, we think Hikma has reached a turning point. Upgrade to Buy.’ Time will tell but hopefully we have neared the bottom ready for a gentle rise back up.
Another positive write up by Simon Thompson today in the IC, a snippet....... ‘I maintain my view that any deal will place a value on the equity in excess of the 13p a share that Goldstream Capital Management, a company owned by Hony Capital, a leading Chinese private equity company, paid for its 6 per cent stake in 2016.’ ‘I maintain my positive stance ahead of a possible successful conclusion to the strategic review, and full-year results that will make for a good read. Buy. It’s this allusive deal we are waiting to hear about of course! But hopefully it may have a positive effect on the share price in the interim!
Might see a little boost Monday....... https://www.thetimes.co.uk/article/share-of-the-week-greencore-group-lr86s95gj
oldabutnowisa been holding for a while myself! after profiting from the special divi on the one hand and having had it taken away by the share consolidation in the other! I was hopeful of a rise, alas it was not meant to be. Im still happy to hold for now picking up a great divi and looking for a top up opportunity when it presents itself! The big Buy has to be the first tick in the box for me but as u say it’d be nice for a few more to jump onboard too! Holding for now but will continue to look for more encouraging signs that might indicate a reversal northwards!
Finally admitted defeat and sold out. KSK power venture interims out today and weren’t particularly inspiring. One to keep on the watch list and return in 2019 or when some positive momentum returns. GL all those holding on.
A very quiet board this! Nice to see two further very large Buys from the non exec chairman and CFO this side of Christmas after the large Buy from the non exec director in October. A hefty 50% discount to October�s price, perhaps some value to be had here?! Any thoughts welcome!
aspers I wish I’d have bailed at 53p! Held on in the vain hope of a recovery but sold out this morning with over 50% loss. RNS didn’t read well with MORE delays on the final results! Good luck to all those hanging on but I can’t bare to watch any longer!
Simon Thompson’s recommended Kromek again today in the IC, articles too big to post, suffice to say it was positive. ‘I feel the risk:reward is very favourable. Trading on a 1.5 times book value, and a modest three times forecast 2018/2019 sales to enterprise value, I rate Kromek shares a buy and maintain my 34p target price. Buy.’
I want to love MTC, strong brand specialising in an area where people are willing to spend good money for quality products, unfortunately a lot of these products can now be bought cheaper elsewhere. Other than a short term potential gain from a takeover offer I’m not sure how they’ll compete with the supermarkets and online. Staying out for now....